カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の豚インフルエンザワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Swine Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19649）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19649
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の豚インフルエンザワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

豚インフルエンザワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の豚インフルエンザワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

豚インフルエンザワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・皮内接種、筋肉内接種、皮下接種、その他

用途別セグメントは次のように区分されます。
・病院薬局、小売薬局、オンライン薬局、診療所＆予防接種センター

世界の豚インフルエンザワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Novartis、CSL Limited、Zydus Cadila、AstraZeneca、GlaxoSmithKline、Sanofi、Baxter、Sinovac Biotech

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、豚インフルエンザワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚インフルエンザワクチンメーカーの企業概要、2019年～2022年までの豚インフルエンザワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚インフルエンザワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別豚インフルエンザワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの豚インフルエンザワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での豚インフルエンザワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および豚インフルエンザワクチンの産業チェーンを掲載しています。
・第13、14、15章では、豚インフルエンザワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 豚インフルエンザワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：皮内接種、筋肉内接種、皮下接種、その他
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、小売薬局、オンライン薬局、診療所＆予防接種センター
- 世界の豚インフルエンザワクチン市場規模・予測
- 世界の豚インフルエンザワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis、CSL Limited、Zydus Cadila、AstraZeneca、GlaxoSmithKline、Sanofi、Baxter、Sinovac Biotech
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：皮内接種、筋肉内接種、皮下接種、その他
・用途別分析2017年-2028年：病院薬局、小売薬局、オンライン薬局、診療所＆予防接種センター
・豚インフルエンザワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚インフルエンザワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚インフルエンザワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚インフルエンザワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・豚インフルエンザワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Swine Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Swine Flu Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Swine Flu Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intradermal Vaccination segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Swine Flu Vaccine include Novartis, CSL Limited, Zydus Cadila, AstraZeneca, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Swine Flu Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Clinic And Vaccination Centers
The key market players for global Swine Flu Vaccine market are listed below:
Novartis
CSL Limited
Zydus Cadila
AstraZeneca
GlaxoSmithKline
Sanofi
Baxter
Sinovac Biotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Swine Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Swine Flu Vaccine, with price, sales, revenue and global market share of Swine Flu Vaccine from 2019 to 2022.
Chapter 3, the Swine Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Swine Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Swine Flu Vaccine.
Chapter 13, 14, and 15, to describe Swine Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Swine Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Swine Flu Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intradermal Vaccination
1.2.3 Intramuscular Vaccination
1.2.4 Subcutaneous Vaccination
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Swine Flu Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Clinic And Vaccination Centers
1.4 Global Swine Flu Vaccine Market Size & Forecast
1.4.1 Global Swine Flu Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Swine Flu Vaccine Sales in Volume (2017-2028)
1.4.3 Global Swine Flu Vaccine Price (2017-2028)
1.5 Global Swine Flu Vaccine Production Capacity Analysis
1.5.1 Global Swine Flu Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Swine Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Swine Flu Vaccine Market Drivers
1.6.2 Swine Flu Vaccine Market Restraints
1.6.3 Swine Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Swine Flu Vaccine Product and Services
2.1.4 Novartis Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL Limited
2.2.1 CSL Limited Details
2.2.2 CSL Limited Major Business
2.2.3 CSL Limited Swine Flu Vaccine Product and Services
2.2.4 CSL Limited Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Swine Flu Vaccine Product and Services
2.3.4 Zydus Cadila Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Swine Flu Vaccine Product and Services
2.4.4 AstraZeneca Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Swine Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Swine Flu Vaccine Product and Services
2.6.4 Sanofi Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business
2.7.3 Baxter Swine Flu Vaccine Product and Services
2.7.4 Baxter Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Swine Flu Vaccine Product and Services
2.8.4 Sinovac Biotech Swine Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Swine Flu Vaccine Breakdown Data by Manufacturer
3.1 Global Swine Flu Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Swine Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Swine Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Swine Flu Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Swine Flu Vaccine Manufacturer Market Share in 2021
3.5 Global Swine Flu Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Swine Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Swine Flu Vaccine Market Size by Region
4.1.1 Global Swine Flu Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Swine Flu Vaccine Revenue by Region (2017-2028)
4.2 North America Swine Flu Vaccine Revenue (2017-2028)
4.3 Europe Swine Flu Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Swine Flu Vaccine Revenue (2017-2028)
4.5 South America Swine Flu Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Swine Flu Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Swine Flu Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Swine Flu Vaccine Revenue by Type (2017-2028)
5.3 Global Swine Flu Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Swine Flu Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Swine Flu Vaccine Revenue by Application (2017-2028)
6.3 Global Swine Flu Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Swine Flu Vaccine Sales by Type (2017-2028)
7.2 North America Swine Flu Vaccine Sales by Application (2017-2028)
7.3 North America Swine Flu Vaccine Market Size by Country
7.3.1 North America Swine Flu Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Swine Flu Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Swine Flu Vaccine Sales by Type (2017-2028)
8.2 Europe Swine Flu Vaccine Sales by Application (2017-2028)
8.3 Europe Swine Flu Vaccine Market Size by Country
8.3.1 Europe Swine Flu Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Swine Flu Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Swine Flu Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Swine Flu Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Swine Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Flu Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Swine Flu Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Swine Flu Vaccine Sales by Type (2017-2028)
10.2 South America Swine Flu Vaccine Sales by Application (2017-2028)
10.3 South America Swine Flu Vaccine Market Size by Country
10.3.1 South America Swine Flu Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Swine Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Swine Flu Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Swine Flu Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Swine Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Flu Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Swine Flu Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Swine Flu Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Swine Flu Vaccine
12.3 Swine Flu Vaccine Production Process
12.4 Swine Flu Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Swine Flu Vaccine Typical Distributors
13.3 Swine Flu Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Swine Flu Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Swine Flu Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Swine Flu Vaccine Product and Services
Table 6. Novartis Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 8. CSL Limited Major Business
Table 9. CSL Limited Swine Flu Vaccine Product and Services
Table 10. CSL Limited Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 12. Zydus Cadila Major Business
Table 13. Zydus Cadila Swine Flu Vaccine Product and Services
Table 14. Zydus Cadila Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Swine Flu Vaccine Product and Services
Table 18. AstraZeneca Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Swine Flu Vaccine Product and Services
Table 22. GlaxoSmithKline Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Swine Flu Vaccine Product and Services
Table 26. Sanofi Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Baxter Basic Information, Manufacturing Base and Competitors
Table 28. Baxter Major Business
Table 29. Baxter Swine Flu Vaccine Product and Services
Table 30. Baxter Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 32. Sinovac Biotech Major Business
Table 33. Sinovac Biotech Swine Flu Vaccine Product and Services
Table 34. Sinovac Biotech Swine Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Swine Flu Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Swine Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Swine Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Swine Flu Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Swine Flu Vaccine Production Site of Key Manufacturer
Table 40. Swine Flu Vaccine New Entrant and Capacity Expansion Plans
Table 41. Swine Flu Vaccine Mergers & Acquisitions in the Past Five Years
Table 42. Global Swine Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 43. Global Swine Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 44. Global Swine Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Swine Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Global Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Global Swine Flu Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Swine Flu Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Swine Flu Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Swine Flu Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Global Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Global Swine Flu Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Swine Flu Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Swine Flu Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Swine Flu Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Swine Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. North America Swine Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. North America Swine Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Swine Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. North America Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. North America Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. North America Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Swine Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Swine Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Swine Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Swine Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Europe Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Europe Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Europe Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Swine Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Swine Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Swine Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Swine Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. South America Swine Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 83. South America Swine Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 84. South America Swine Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Swine Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. South America Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. South America Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. South America Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Swine Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Swine Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Swine Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Swine Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Swine Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Swine Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Swine Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Swine Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Swine Flu Vaccine Raw Material
Table 99. Key Manufacturers of Swine Flu Vaccine Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Swine Flu Vaccine Typical Distributors
Table 103. Swine Flu Vaccine Typical Customers
List of Figures
Figure 1. Swine Flu Vaccine Picture
Figure 2. Global Swine Flu Vaccine Revenue Market Share by Type in 2021
Figure 3. Intradermal Vaccination
Figure 4. Intramuscular Vaccination
Figure 5. Subcutaneous Vaccination
Figure 6. Others
Figure 7. Global Swine Flu Vaccine Revenue Market Share by Application in 2021
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Clinic And Vaccination Centers
Figure 12. Global Swine Flu Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Swine Flu Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Swine Flu Vaccine Sales (2017-2028) & (K Units)
Figure 15. Global Swine Flu Vaccine Price (2017-2028) & (US$/Unit)
Figure 16. Global Swine Flu Vaccine Production Capacity (2017-2028) & (K Units)
Figure 17. Global Swine Flu Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Swine Flu Vaccine Market Drivers
Figure 19. Swine Flu Vaccine Market Restraints
Figure 20. Swine Flu Vaccine Market Trends
Figure 21. Global Swine Flu Vaccine Sales Market Share by Manufacturer in 2021
Figure 22. Global Swine Flu Vaccine Revenue Market Share by Manufacturer in 2021
Figure 23. Swine Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Swine Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Swine Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Swine Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 27. Global Swine Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 28. North America Swine Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Europe Swine Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Swine Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. South America Swine Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Swine Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. Global Swine Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 34. Global Swine Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. Global Swine Flu Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Global Swine Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. Global Swine Flu Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Swine Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 40. North America Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 41. North America Swine Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 42. North America Swine Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 43. United States Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Swine Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 47. Europe Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 48. Europe Swine Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 49. Europe Swine Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 50. Germany Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Swine Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Swine Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Swine Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 59. China Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Swine Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 66. South America Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 67. South America Swine Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 68. South America Swine Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Swine Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Swine Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Swine Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Swine Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Swine Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Swine Flu Vaccine in 2021
Figure 80. Manufacturing Process Analysis of Swine Flu Vaccine
Figure 81. Swine Flu Vaccine Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の家畜用ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン多価市場2022年：市場規模予測（～2028年）
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界の獣医用ウイルスベクター化ワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19649 )"世界の豚インフルエンザワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Swine Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。